Document:

EX-10.2

 Exhibit 10.2 

STONE ENERGY CORPORATION 

DIRECTORS DEFERRED COMPENSATION PLAN 

1.    Establishment. Stone Energy Corporation, a corporation organized in the State of Delaware (the
“Company”), hereby adopts and establishes an unfunded deferred compensation plan for non-employee directors of the Company, which shall be known as the Stone Energy Corporation Deferred
Compensation Plan (the “DCP”). The DCP is a sub-plan under the Stone Energy Corporation 2017 Long Term Incentive Plan (the “Plan”). 

2.    Purpose. The purpose of the DCP is to provide each non-employee
director of the Company the ability to defer receipt of shares of Common Stock issued in respect of equity-based awards received by such non-employee director for her or his service to the Company until a
future date chosen by such non-employee director. 
 3.    Incorporation By
Reference; Plan Document Receipt. This DCP is subject in all respects to the terms and provisions of the Plan (including, without limitation, any amendments thereto adopted at any time and from time to time unless such amendments are expressly
intended not to apply to the Award provided hereunder), all of which terms and provisions are made a part of and incorporated into this DCP as if they were each expressly set forth herein. Except as provided otherwise herein, any capitalized term
not defined in this DCP shall have the same meaning as is ascribed thereto in the Plan. The Participant hereby acknowledges receipt of a true copy of the Plan and this DCP and that the Participant has read the Plan and this DCP carefully and fully
understands the content of each of them. In the event of any conflict between the terms of this Agreement and the terms of the Plan, the terms of the Plan shall control. 

4.    Definitions. 

“Acceleration Events” is defined in Section 11.1 hereof. 

“Account” means a hypothetical bookkeeping account established in the name of each Participant and maintained
by the Company to reflect the Participant’s interests under the DCP. 
 “Beneficiary” means any person
or entity, designated in accordance with Section 13.7, entitled to receive benefits which are payable upon or after a Participant’s death pursuant to the terms of the DCP. 

“Change in Control” shall mean a “Corporate Change” as defined in the Plan; provided that such
Corporate Change constitutes a “change in control event” within the meaning of Treas. Regs. Section 1.409A-3(i)(5). 

“DCP” means this Stone Energy Corporation Deferred Compensation Plan, as amended from time to time. 

 “Deferral Election” means an election by an Eligible Director to
defer Equity Compensation. 
 “Distribution Date” means a date specified by a Participant in his or her
Election Notice for the payment of all or a portion of such Participant’s Account. 
 “Effective Date”
means March 1, 2017. 
 “Election Notice” means the notice or notices provided from time to time by the
Committee to Participants for purposes of permitting the Participants to make Deferral Elections under the DCP. The Election Notice returned to the Committee by any Participant shall conform to the requirements of Section 6 and any other
applicable provisions of the DCP and shall include the percentage of Equity Awards to be deferred; the Distribution Date(s); and the form of payment being made in a one (1) time lump sum. The form Election Notice is attached hereto and
incorporated herein as Exhibit A. Each Election Notice shall become irrevocable as of the last day of the Election Period. 

“Election Period” means the period established by the Committee with respect to each Plan Year during which
Deferral Elections for such Plan Year must be made in accordance with the requirements of Section 409A of the Code, as follows: 

(a)    General Rule. Except as provided in (b) below, the Election Period shall end no later
than the last day of the calendar year immediately preceding the Plan Year to which the Deferral Election relates. 

(b)    Newly Eligible Directors. The Election Period for newly Eligible Directors shall end no later
than thirty (30) days after the non-employee director first becomes eligible to participate in the DCP and shall apply only with respect to compensation earned after the date of the Deferral Election.

 “Eligible Director” means each non-employee director of the
Company. 
 “Equity Compensation” means any equity-based incentive compensation awards received by a
Participant for his or her service as a director pursuant to the Plan or any successor thereto. 

“Participant” means an Eligible Director who elects to participate in the DCP by filing an Election Notice in
accordance with Section 6.1 and any former Eligible Director who continues to be entitled to a benefit under the DCP. 

“Plan Year” means the period which begins on the date of the Company’s annual meeting shareholders for a
given year, or initially on the date of adoption of the Plan, and ends on the date immediately prior to the next succeeding annual meeting shareholders in the following calendar year. 

“Separation from Service” has the meaning set forth in Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. Section 1.409A-1(h). 

  
 2 

 “Unforeseeable Emergency” means a severe financial hardship of
the Participant resulting from (a) an illness or accident of the Participant, the Participant’s spouse, or the Participant’s dependent; (b) a loss of the Participant’s property due to casualty; or (c) such other similar
extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant, all as determined in the sole discretion of the Committee. 

“Vesting Date” means the date that Equity Compensation becomes vested and
non-forfeitable pursuant to the award agreement granting the Equity Compensation. 

5.    Eligibility; Participation. 

5.1    Requirements for Participation. Any Eligible Director may participate in the DCP commencing
as of the date on which he or she becomes an Eligible Director. An Eligible Director may become a Participant in the DCP by making a Deferral Election in accordance with Section 6. 

6.    Election Procedures. 

6.1    Deferral Election. An Eligible Director may elect to defer Equity Compensation by completing
an Election Notice and filing it with the Committee during the Election Period. The Election Notice must specify: 

(a)    The percentage of Equity Compensation to be deferred; 

(b)    The Distribution Date for the Participant’s Account (subject to the provisions of the DCP); and

 (c)    The form of payment for the Participant’s Account being made in a lump sum. 

6.2    Equity Compensation Deferrals. A Participant may elect to defer receipt of up to 100% of the
Participant’s Equity Compensation for any Plan Year by making a Deferral Election in accordance with this Section 6. Equity Compensation Deferrals shall be credited to the Participant’s Account as of the date the deferred Equity
Compensation otherwise would have been settled. 
 7.    Accounts. 

7.1    Establishment of Accounts. The Company shall establish and maintain an Account for each
Participant. The Company may establish more than one Account on behalf of any Participant as deemed necessary by the Committee for administrative purposes. 

7.2    Crediting of Account. The Committee will credit to the Participant’s Account a number of
shares of Common Stock equal to the number of shares of Common Stock otherwise deliverable to the Participant in respect of the deferred Equity Compensation absent such Participant’s Deferral Election. The number of shares of Common Stock
credited to a Participant’s Account are subject to adjustment in accordance with Section 9 of the Plan. 

  
 3 

 7.3    Dividend Equivalents. As of the date of payment
of any cash dividend on Common Stock, the Committee will credit to the Account a number of shares equal to the cash dividend per share times the number of shares credited to the Account as of the dividend record date divided by the Fair Market Value
of the shares of Common Stock. As of the date of payment of any stock dividend on Common Stock, the Committee will credit to the Account a number of shares of Common Stock equal to the stock dividend declared times the number of shares of Common
Stock credited to the Account as of the dividend record date. 
 7.4    Nature of Accounts. The
Account is maintained for bookkeeping purposes only. Shares of Common Stock credited to the Account are not considered actual shares of Common Stock of the Company for any purpose and a Participant will have no rights as a stockholder with respect
to such shares of Common Stock. Shares will include fractional shares of Common Stock computed to three decimal places. 

8.    Vesting. 

8.1    Vesting of Equity Compensation Deferrals. Participants shall be fully vested at all times in
their Equity Compensation deferrals and any Dividend Equivalents made with respect thereto. 
 9.    Payment of
Participant Accounts. 
 9.1    In General. Payment of a Participant’s Account shall be
made (or commence, in the case of installments) on the earliest to occur of the following events (each a “Payment Event”): 

(a)    The Distribution Date specified in the Participant’s Deferral Election; provided that, the
Participant must select from among the available Distribution Date(s) designated by the Committee and set forth in the Election Notice; 

(b)    The Participant’s Separation from Service; 

(c)    The Participant’s death; and 

(d)    The occurrence of a Corporate Change. 

9.2    Timing of Payments. Except as otherwise provided in this Section 9, payments shall be
made or commence within 10 business days following a Payment Event. 
 9.3    Form of Payment.
Each Participant shall specify in his or her Election Notice that the form of payment will be in a one (1) time lump sum for amounts in his or her Account that are covered by the election. 

  
 4 

 9.4    Medium of Payment. Payment of a
Participant’s Account shall be made in accordance with the form of payment provided for in the applicable Equity Compensation award agreement; provided any fractional shares shall be paid in cash based on the Fair Market Value of the
shares of Common Stock on at the time of the Payment Event. 
 10.    Payments Due to Unforeseeable Emergency.

 10.1    Request for Payment. If a Participant suffers an Unforeseeable Emergency, he or she may
submit a written request to the Committee for payment of his or her Account. 
 10.2    No Payment If
Other Relief Available. The Committee will evaluate the Participant’s request for payment due to an Unforeseeable Emergency taking into account the Participant’s circumstances and the requirements of Section 409A of the Code. In no
event will payments be made pursuant to this Section 10 to the extent that the Participant’s hardship can be relieved: (a) through reimbursement or compensation by insurance or otherwise; or (b) by liquidation of the
Participant’s assets, to the extent that liquidation of the Participant’s assets would not itself cause severe financial hardship; or (c) by the cessation of deferrals under the DCP. 

10.3    Limitation on Payment Amount. The amount of any payment made on account of an Unforeseeable
Emergency shall not exceed the amount reasonably necessary to satisfy the Participant’s financial need, including amounts necessary to pay any Federal, state or local income taxes or penalties reasonably anticipated to result from the payment,
as determined by the Committee. 
 10.4    Timing of Payment. Payments shall be made from a
Participant’s Account as soon as practicable and in any event within 10 business days following the Committee’s determination that an Unforeseeable Emergency has occurred and authorization of payment from the Participant’s Account.

 11.    Acceleration Events. 

11.1    Permissible Acceleration Events. Notwithstanding anything in the DCP to the contrary, the
Committee, in its sole discretion, may accelerate payment of all or a portion of a Participant’s Account upon the occurrence of any of the events (“Acceleration Events”) set forth in this Section 11. The Committee’s
determination of whether payment may be accelerated in accordance with this Section 11 shall be made in accordance with Treas. Reg. Section 1.409A-3(j)(4). 

(a)    Domestic Relations Orders. The Committee may accelerate payment of a Participant’s
Account to the extent necessary to comply with a domestic relations order (as defined in Section 414(p)(1)(B) of the Code). 

(b)    Limited Cashouts. The Committee may accelerate payment of a Participant’s Account
to the extent that (i) the aggregate amount in the Participant’s Account does not exceed the applicable dollar amount under Section 402(g)(1)(B) of the Code, (ii) the payment results in the termination of the Participant’s entire
interest in the DCP and any plans that are aggregated with the DCP pursuant to Treas. Reg. Section 1.409A-1(c)(2), and (iii) the Committee’s decision to cash out the Participant’s Account is
evidenced in writing no later than the date of payment. 

  
 5 

 (c)    Payment of Employment Taxes. The Committee may
accelerate payment of all or a portion of a Participant’s Account (i) to pay the Federal Insurance Contributions Act (FICA) tax imposed under Sections 3010, 3121(a) and 3121(v)(2) of the Code (the “FICA Amount”), or
(ii) to pay the income tax at source on wages imposed under Section 3401 of the Code or the corresponding withholding provisions of applicable state, local or foreign tax laws as a result of the payment of the FICA Amount and the
additional income tax at source on wages attributable to the pyramiding Section 3401 wages and taxes; provided, however, that the total payment under this Section 11.1(c) shall not exceed the FICA Amount and the income tax withholding related
to the FICA Amount. 
 (d)    Payment Upon Income Inclusion. The Committee may accelerate payment
of all or a portion of a Participant’s Account to the extent that the DCP fails to meet the requirements of Section 409A of the Code; provided that, the amount accelerated shall not exceed the amount required to be included in income as a
result of the failure to comply with Section 409A of the Code. 
 (e)    Termination of the DCP.
The Committee may accelerate payment of all or a portion of a Participant’s Account upon termination of the DCP in accordance with Treas. Reg. Section 1.409A-3(j)(4)(ix). 

(f)    Payment of State, Local or Foreign Taxes. The Committee may accelerate payment of all or a
portion of a Participant’s Account for: 
 (i)    the payment of state, local or foreign tax
obligations arising from participation in the DCP that relate to an amount deferred under the DCP before the amount is paid or made available to the Participant (the “State, Local and Foreign Tax Amount”); provided, however, the
accelerated payment amount shall not exceed the taxes due as a result of participation in the DCP, and/or 

(ii)    the payment of income tax at source on wages imposed under Section 3401 of the Code as a
result of such payment and the payment of the additional income tax at source on wages imposed under Section 3401 of the Code attributable to the additional Section 3401 wages and taxes; provided however, the accelerated payment amount
shall not exceed the aggregate of the State, Local and Foreign Tax Amount and the income tax withholding related to such amount. 

(g)    Certain Offsets. The Committee may accelerate payment of all or a portion of the
Participant’s Account to satisfy a debt of the Participant to the Company incurred in the ordinary course of the service relationship between the Company and the Participant; provided, however, the amount accelerated shall not exceed $5,000 and
the payment shall be made at the same time and in the same amount as the debt otherwise would have been due and collected from the Participant. 

  
 6 

 (h)    Bona Fide Disputes as to Right to Payment. The
Committee may accelerate payment of all or a portion of a Participant’s Account where the payment is part of a settlement between the Company and the Participant of an arm’s length, bona fide dispute as to the Participant’s right to
the deferred amount. 
 12.    Amendment and Termination. 

12.1    The Board may, at any time, and in its discretion, alter, amend, modify, suspend or terminate the
DCP or any portion thereof; provided, however, that no such amendment, modification, suspension or termination shall, without the consent of a Participant, adversely affect such Participant’s rights with respect to amounts credited to or
accrued in his or her Account and provided, further, that, no payment of benefits shall occur upon termination of the DCP unless the requirements of Section 409A of the Code have been met. 

13.    Miscellaneous. 

13.1    No Employment or Other Service Rights. Nothing in the DCP or any instrument executed
pursuant thereto shall confer upon any Participant any right to continue to serve the Company or interfere in any way with the right of the Company to terminate the Participant’s service at any time with or without notice and with or without
cause. 
 13.2    Tax Withholding. The Company shall have the right to deduct from any amounts
otherwise payable under the DCP any Federal, state, local, or other applicable taxes required to be withheld. 

13.3    Governing Law. The DCP shall be administered, construed and governed in all respects under
and by the laws of Delaware, without reference to the principles of conflicts of law (except and to the extent preempted by applicable Federal law). 

13.4    Section 409A of the Code. The Company intends that the DCP comply with the requirements of
Section 409A of the Code and shall be operated and interpreted consistent with that intent. Notwithstanding the foregoing, the Company makes no representation that the DCP complies with Section 409A of the Code and shall have no liability to any
Participant for any failure to comply with Section 409A of the Code. 
 13.5    General
Assets/Trust. All amounts provided under the DCP shall be paid from the general assets of the Company and no separate fund shall be established to secure payment. Notwithstanding the foregoing, the Company may, but need not, establish a rabbi
trust to assist it in funding any DCP obligations. 
 13.6    No Warranties. Neither the Company
nor the Committee warrants or represents that the value of any Participant’s Account will increase. Each Participant assumes the risk in connection with the deemed investment of his or her Account. 

  
 7 

 13.7    Beneficiary Designation. Each Participant
under the DCP may from time to time name any beneficiary or beneficiaries to receive the Participant’s interest in the DCP in the event of the Participant’s death. Each designation will revoke all prior designations by the same
Participant, shall be in a form reasonably prescribed by the Committee and shall be effective only when filed by the Participant in writing with the Company during the Participant’s lifetime. If a Participant fails to designate a beneficiary,
then the Participant’s designated beneficiary shall be deemed to be the Participant’s estate. 

13.8    No Assignment. Neither a Participant nor any other person shall have any right to sell,
assign, transfer, pledge, anticipate or otherwise encumber, transfer, hypothecate or convey any amounts payable hereunder prior to the date that such amounts are paid (except for the designation of beneficiaries pursuant to Section 13.7). 

13.9    Expenses. The costs of administering the DCP shall be paid by the Company. 

13.10    Severability. If any provision of the DCP is held to be invalid, illegal or unenforceable,
whether in whole or in part, such provision shall be deemed modified to the extent of such invalidity, illegality or unenforceability and the remaining provisions shall not be affected. 

13.11    Headings and Subheadings. Headings and subheadings in the DCP are for convenience only and
are not to be considered in the construction of the provisions hereof. 
 *  *  *  *  * 

IN WITNESS WHEREOF, STONE ENERGY CORPORATION has adopted this DCP as of the Effective Date written above. 

 

			
	STONE ENERGY CORPORATION
		
	By:	 	 /s/ Neal P. Goldman

	Name:	 	Neal P. Goldman
	Title:	 	Chairman of the Board

  
 8 

 EXHIBIT A 

FORM ELECTION NOTICE UNDER 

STONE ENERGY CORPORATION DIRECTORS DEFERRED COMPENSATION PLAN 

[See Next Page] 

  
 9 

 STONE ENERGY CORPORATION 

DIRECTORS DEFERRED COMPENSATION PLAN 

ELECTION NOTICE FOR THE [            ] PLAN YEAR 

This Election Notice must be completed and returned to the General Counsel at Stone Energy Corporation (the “Company”) by no
later than December 31, [            ] (the “Election Deadline”); provided, that, if you are a newly Eligible Director, as determined by the Committee, the
Election Deadline is the 30th day after you become an Eligible Director. Your election becomes irrevocable as of the Election Deadline. 

Pursuant to the terms of the Stone Energy Corporation Deferred Compensation Plan (the “DCP”), I hereby elect to defer certain
of my compensation for the [            ] Plan Year in accordance with this election. Capitalized terms used but not defined herein have the meanings set forth in the DCP. 

Equity Compensation Deferral Election 

Pursuant to Section 6 of the DCP, I hereby elect to defer
(            ) percent (            %) of the shares of Common Stock deliverable pursuant to my Equity
Compensation, if any, rounded down to the nearest whole share for the [            ] Plan Year in accordance with this election. 

Distribution Date Election 
 I
hereby elect the following Distribution Date: 
          Third anniversary of the Vesting
Date; or 
          Date of Separation from Service with the Board 

Other Payment Events 

Notwithstanding the above Distribution Date election, if any of the following Payment Events occurs prior to the Distribution Date, payment
shall be made in accordance with Section 9 of the DCP: 
  

	 	•	 	Separation from Service. 

  

	 	•	 	Death. 

  

	 	•	 	Change in Control as defined in the DCP. 

 Form of Payment 

I hereby elect to receive one (1) lump sum payment with respect to amounts deferred hereunder. 

  
 10 

 Section 409A of the Code 

I understand that the DCP is intended to comply with Section 409A of the Code and that it will be interpreted accordingly. However, I also
understand that the Company will have no liability with respect to any failure to comply with Section 409A of the Code. 
 Subsequent Plan Years

 I understand that this Deferral Election applies only with respect to compensation earned for services performed during the
[            ] Plan Year. I hereby acknowledge that if I wish to defer any of my compensation with respect to future Plan Years, I will need to make a new Deferral Election by
completing another Election Notice and submitting it to the Committee on or before the Election Deadline for such Plan Year. 
 Acknowledgement

 By executing this Election Notice I acknowledge that: 
  

	 	•	 	I have read and understand the terms of the DCP and agree to all of its terms and conditions. 

  

	 	•	 	I understand that any amounts I defer hereunder are unfunded and unsecured and subject to the claims of the Company’s creditors in the event of the Company’s insolvency. 

 

	 	•	 	I have consulted with my own tax advisor regarding the tax consequences of participating in the DCP and making this election. 

*  *  *  *  * 

  
 11 

 I hereby make this election as of this         
day of                     ,             . 

 

	
	  

	
	Participant’s Signature
	
	  

	
	Print Participant’s Name
	
	  

	
	 Copy received this          day of

                    ,
            .

	
	  

	
	[Committee Member]

  
 12Confidential Treatment Requested by AdvanSix
Inc.

 

Exhibit 10.21

 

FIFTH AMENDMENT

TO AMENDED AND RESTATED

CAPROLACTAM AND POLYMER SUPPLY AGREEMENT

 

THIS FIFTH AMENDMENT TO AMENDED AND RESTATED
CAPROLACTAM AND POLYMER SUPPLY AGREEMENT (this “Amendment”) is entered into as of March 1, 2017, by and between
AdvanSix Resins & Chemicals LLC (“Seller”), and Shaw Industries Group, Inc., a Georgia corporation
(“Buyer”).

 

Recitals

 

WHEREAS, on April 1, 2013,
Seller and Buyer entered into that certain Amended and Restated Caprolactam and Polymer Supply Agreement (as amended, the “Agreement”);

 

WHEREAS, the parties desire
to amend certain provisions of the Agreement; and

 

WHEREAS, capitalized terms
not otherwise defined herein shall have the meanings ascribed to them in the Agreement.

 

Agreement

 

NOW, THEREFORE, in consideration of
the mutual terms, conditions and other agreements set forth herein, the parties, intending to be legally bound hereby, agree as
follows:

 

1.         Section 1.8 of the Agreement is deleted
in its entirety, and inserted in lieu thereof is a new Section 1.8, as follows:

 

1.8. Washwater Supply. From January
1, 2017 through the last day of the term of the Agreement, Buyer shall supply to Seller and Seller shall purchase from Buyer the
Wash water. Such Washwater shall contain on average for each Fiscal Year during the Term at least [***] percent ([***]%) monomer
equivalent caprolactam.

 

2.         Section 1.9 of the Agreement is deleted
in its entirety, and inserted in lieu thereof is a new Section 1.9, as follows:

 

“1.9 [***] Volume
Adjustment. Notwithstanding Article 1.2 of this Agreement, between [***],
through [***], (i) the annual Minimum Volume shall be [***]
([***]) pounds of Product, and (ii) the annual Maximum Volume shall be [***]
([***]) pounds of Product. Notwithstanding Article 1.2(a) of the Agreement, the minimum
annual volume for Polymer shall be [***] pounds ([***])
and the maximum annual volume for Polymer shall be [***] pounds ([***])
from [***], through [***].

    	 

    	

    
Confidential Treatment Requested by AdvanSix
Inc.

 

The resulting total product mix for [***]
([***]) pounds is [***] ([***])
pounds of [***] Caprolactam [***] and [***] ([***])
pounds of [***] polymer. Seller may substitute [***] polymer
for [***] polymer.”

 

3.         Section 1.4 of the Agreement is deleted in its entirety, and
inserted in lieu is a new Section 1.4, as follows:

 

“1.4 Further Volume Adjustments. Notwithstanding any of the foregoing contained in this Agreement, overall volume ranges of
Product to be purchased by the Buyer during the periods described in the Agreement may be amended, with respect to any [***]
([***])-month period, to reflect an increase or decrease in the annualized rate in an
amount not to exceed [***] ([***]) pounds, with [***]
([***]) days prior written notice by the Buyer to Seller; provided, however, that under
no circumstance shall the Buyer be entitled to purchase Product at an annualized rate of more than [***]
([***]) pounds. In the event of any such amendment, notwithstanding the provisions of the
Agreement, such range of annualized rate of Product to be purchased by the Buyer established by such an amendment shall
remain in effect until such time, if any, that the Buyer shall again exercise its rights under and subject to this Article
1.4 to further increase or decrease in the minimum and/or maximum annualized rate of Product to be purchased by the Buyer
then-in-effect in an amount not to exceed [***] ([***])
pounds.”

 

4.         Section 2.1 of the Agreement is deleted
in its entirety, and inserted in lieu thereof is a new Section 2.1, as follows:

 

“2.1 Caprolactam
Pricing. The price for each pound of [***] Caprolactam shall be the sum of (x) [***]
($[***]) plus (y) the Caprolactam Index Amount (as defined in Schedule 2.1(I)), which,
may be a positive or a negative amount, plus (z) the Caprolactam Adder Amount. The Caprolactam Adder Amount shall be: (i) for
the period of [***], through [***], [***]
($[***]) per pound of Product, (ii) for the period of [***],
through [***], [***] ($[***])
per pound of Product, and (iii) for the period of [***], through the last day of the
Term, [***] ($[***]) per pound of Product.”

 

5.         Section 2.4 of the Agreement is deleted
in its entirety, and inserted in lieu thereof is a new Section 2.4, as follows:

 

2.4. Washwater Pricing. The price
for each pound of Washwater shall be equal to (A) the

percentage of caprolactam contained
in such pound multiplied by the price per pound of  [***]
Caprolactam (calculated pursuant to Article 2.1) in effect from time to time under this Agreement, minus (B)
[***] ($[***]). The percentage of caprolactam contained in a pound of Washwater shall be calculated by Seller at its Hopewell
facility, using Seller’s test method QALAC-0029 (Attachment I to this Amendment) or other mutually agreed method and
shall include only monomer equivalent caprolactam, with no credit being given for any oligomers present in the

    	 

    	

    
Confidential Treatment Requested by AdvanSix
Inc.

 

Washwater. If
in any Fiscal Year the average percentage of caprolactam in all Washwater supplied that year is not at least [***] ([***]%),
then Seller may invoice Buyer for an increased pro-rata share of its caprolactam recovery costs commensurate with the actual percentage
of caprolactam contained in Washwater during the year.

 

6.         Steam - Steam shall be redefined
as the average actual dollars per [***] pounds of delivered steam for the previous [***],
in US dollars, as reported by Seller. Seller will provide a written [***] summary.

 

7.         All capitalized terms used, but not defined,
herein shall have the meaning set forth in the Agreement.

 

8.         This Amendment may be executed in counterparts,
each of which shall be deemed an original but all of which shall constitute one and the same agreement.

 

9.         Except as expressly modified in this
Amendment, the Agreement remains in full force and effect. The Agreement and this Amendment together constitute the entire agreement
between the Parties with respect to the subject matter hereof, and supersede all prior agreements or understandings between the
Parties as to the subject matter hereof.

 

[The
Remainder of this Page has been Intentionally Left Blank]

    	 

    	

    

Confidential Treatment Requested by AdvanSix
Inc.

 

IN WITNESS WHEREOF, the parties have
executed this Fifth Amendment to Caprolactam and Polymer Supply Agreement as of the date first above written.

 

	AdvanSix Resins & chemicals LLC	 	SHAW INDUSTRIES GROUP, INC.
	 	 	 	 	 	 
	By:	/s/ 	Erin Kane	 	By:	/s/ 	David Morgan
	 	 	Erin Kane	 	 		David Morgan
	 	 	President	 	 	 	Executive Vice President Operations

    	 

    	

    

Confidential Treatment Requested by AdvanSix
Inc.

 

Attachment I

 

	 	HOPEWELL PLANT

	 	 
	Quality Assurance Analytical Procedure	Number    QALAC-0029
	Subject: The determination of Caprolactam in Dilute Caprolactam, Wash Water, and Caprolactam (Lactam) Inventory Samples.	Revision   R-7
	 	SupersedesQALAC-0029 R-6

March 13, 2009
	 	Date     June 19, 2012
	Dept Mgt. Approval Dale Nesselrodt Approval Signature Available on Master Copy	Page     1 of 8

 

1.0       PURPOSE

This analytical procedure describes the method for the
determination of Caprolactam in Dilute Caprolactam, Wash Water, and Caprolactam (Lactam) Inventory Samples.

 

2.0       SCOPE

This procedure applies to the analysis of Caprolactam in
Dilute Caprolactam, Wash Water, and Caprolactam (Lactam) Inventory samples from the Caprolactam process at the Hopewell Plant Lactam.

 

3.0       DEFINITIONS

None

 

4.0       SAFETY ISSUES/EQUIPMENT

Standard hand and eye protection is required.

 

5.0       SPECIAL TOOLS/EQUIPMENT/MATERIALS

		5.1	Special Tools/Equipment:

		5.1.1	Glassware associated with standard analytical analysis

		5.1.2	Agilent 6890 gas chromatograph, or equivalent, equipped with a Flame Ionization Detector (FID).

		5.1.3	Agilent VP-Class Data Collection System, or equivalent

		5.1.4	10 mL
syringe or Agilent 7683B Series Automatic Liquid Sampler (ALS)

		5.1.5	A balance capable of weighing to ±
0.01 grams

		5.1.6	A magnetic stirring motor and a magnetic stirring bar

		5.1.7	4 - 8 oz. sample bottles with caps, or 150 mL

Erlenmeyer flasks with stoppers/caps

    	 

    	

    

Confidential Treatment Requested by AdvanSix
Inc.

 

		NOTE:	Glassware used is to be clean, unbroken, and of adequate size and volume capacity to perform this procedure. Adhering to these
conditions, and dependent upon availability, technicians are empowered to select and use glassware for the completion of this procedure.

 

		5.2	Materials:

		5.2.3	Diethyl phthalate (C6H4)-1,2-(CO2C2H5)2, reagent grade

		5.2.4	Methanol (CH3OH), reagent grade

		5.2.5	Distilled water

		5.2.6	Acetone, for syringe washing

 

		NOTE:	Purity of Reagents - Reagent grade chemicals will be used in all tests. Unless otherwise indicated, it is intended that all
reagents will conform to the specifications of the Committee on Analytical Reagents of the American Chemical Society, where such
specifications are available.
	 	 	 
	 	 	Purity of Water - Reference to water shall be understood
to mean reagent water conforming to the specifications for reagent water (ASTM Designation D 1193).

 

6.0       PROCEDURE

 

		6.1	Preparation of Diethyl Phthalate Internal Standard.

 

6.1.1
Transfer 600 ± 0.2
g of Diethyl Phthalate to a 20-L carboy, or equivalent.

 

6.1.2 Dilute to the 20-L mark
with reagent grade Methanol.

 

6.1.3 Insert a paddle mixer wand
attached to a variable speed, electric mixer. Stir the solution until all of the Diethyl Phthalate goes into solution.

 

6.1.4 Keep the solution in the 20-L carboy. Use as needed.

 

6.1.5 Label the solution as follows:

 

6.1.5.1 Diethyl Phthalate Internal Standard

 

6.1.5.2 Preparation date

 

6.1.5.3 Expiration date (3 months
from preparation date)

 

6.1.5.4 Preparer’s initials

    	 

    	

    
Confidential Treatment Requested by AdvanSix
Inc.

 

		6.2	Preparation of Calibration Standard.

 

NOTE: The calibration standard
solution batch size may be increased or decreased as desired by multiplying (or dividing) the components by the same factor. For
example, in step 6.2.4, 4 g of solution may be used as long as 96 g of DEP internal standard solution is added to the standard
solution. Select an appropriately sized mixing container.

 

		6.2.1	Transfer 50 ±
0.2 g finished product Caprolactam (VT-297/360 or flake Lactam) to an 8 oz. sample bottle.

 

		6.2.2	Transfer 50 ±
0.2 g of distilled water to the sample bottle.

 

6.2.3 Cap the sample bottle and
shake vigorously to thoroughly mix the solution.

 

6.2.4 Transfer 2.00 g of the resulting
solution into a 4-oz bottle, or equivalent. Record the weight to the nearest 0.01 g.

6.2.5 Transfer 48.00 g of the
Diethyl Phthalate Internal Standard (prepared in 6.1) into the 4-oz bottle. Record the weight to the nearest 0.01 g.

 

6.2.6 Cap the bottle and shake
vigorously to thoroughly mix the contents.

 

NOTE: The percentage of Caprolactam
in this standard corresponds to 100% Caprolactam. Dilution is necessary for accurate quantitation on the gas chromatograph.

 

6.2.7 Prepare a nominal 50% QA check
standard sample by the following procedure:

6.2.7.1 Transfer 1.00 g of the calibration
solution prepared in step 6.2.6 into a 4-oz bottle. Record the weight to the nearest 0.01 g.

6.2.7.2 Transfer 1.00 g of distilled
water into the 4-oz bottle. Record the weight to the nearest 0.01 g.

6.2.7.3 Transfer 48.00 g of Diethyl
Phthalate Internal Standard solution in to the 4-oz bottle. Record the weight to the nearest 0.01 g. Cap and shake vigorously.

 

6.3 Preparation of Sample

 

6.3.1 Obtain the necessary Caprolactam
sample. Shake the sample bottle vigorously to thorough homogenize the sample.

 

NOTE: Wash water samples
from Chesterfield are brought over to the lab in 4-oz sample bottles as each shipment arrives at the Hopewell Plant. A bi-weekly
composite is prepared on Sunday evenings and Wednesday mornings. The composites are prepared by thoroughly shaking each

    	 

    	

    
Confidential Treatment Requested by AdvanSix
Inc.

 

individual sample and transferring 2-oz of the homogenized
sample into a composite bottle. The remaining individual samples are retained until all analyses are complete and permission to
dispose of the samples is obtained from laboratory supervision. An 8-oz aliquot of the completed composite sample is secured and
retained for future reference, if needed. Place the retained composite sample in the solutions lab where the solutions technician
can record and store the retain sample in its proper storage location. At least three Chesterfield wash water samples must be present
to prepare a composite. If there are fewer than three samples present, then save the samples until the next composite period.

 

6.3.2 Transfer 1.00 g of the Lactam
sample into an 4-oz bottle. Record the weight to the nearest 0.01 g.

 

NOTE: Perform this step immediately
after shaking the sample when analyzing Wash Water. Otherwise, the solids may settle to the bottom of the sample bottle and a non
representative sample will be obtained.

 

6.3.3 Transfer 1.00 g of distilled
water and 48.00 g of the Diethyl Phthalate Internal Standard into the 4-oz bottle. Record the weight of the distilled water and
internal standard to the nearest 0.01 g.

 

6.3.4 Cap the bottle and shake
vigorously to thoroughly mix the sample.

 

6.3.5 Repeat steps 6.3.1 - 6.3.4
for each inventory, wash water or dilute caprolactam sample.

 

		6.4	Method Calibration

 

 6.4.1 Obtain the calibration standard prepared in 6.2.

 

6.4.2 Following the manufacturer’s
instructions, configure the CLASS-VP Data collection system to report the results by Internal Standard calibration using the method
program defined for this analysis. Refer to the current method settings in the GC Reference. Enter the standardization and QA check
sample data and preparation weights into the sequence table.

 

 6.4.3 Prepare an Agilent 6890 gas chromatograph (or equivalent) to operate under the following conditions.

 

	 	Column:	4’ x 1/4” x 2mm I.D. (or 4mm ID) glass, packed with Tenax GC 60/80 mesh Packed

    	 

    	

    

Confidential Treatment Requested by AdvanSix
Inc.

 

	 	 	column or 15 m x 0.53 mm x 1.0 micron RTX-WAX Capillary column or equivalent.
	 	Detector: Flame Ionization	 
	 	 	 
	 	Injection Port Temperature:	320 °C
	 	 	 
	 	Detector Temperature:	350 °C
	 	 	 
	 	Column Oven Temperature:	270 °C Isothermal
	 	 	 
	 	Carrier Gas:	Adjustable to obtain suitable component resolution and analysis time. (nominally 30 mL/min for Packed columns and 5 mL/min for Capillary columns Helium flow)

 

NOTE: The chromatographic
conditions are to be optimized for the best separation and sensitivity for the sample being analyzed. Refer to current chromatographic
conditions in the GC Reference for the particular sample being analyzed.

 

		6.4.4	Using an ALS, equipped with a 10 mL
syringe, inject 1 mL of
Calibration standard into the gas chromatograph and allow the Data collection software operate until the completion of the scan.

 

		6.4.5	Clean the syringe after injecting each standard according to the following procedures:

 

		6.4.5.1	Allow for ALS systems to automatically clean syringes after injection. Verify that all solvent vials are full and waste vials
are empty for ALS systems.

 

		6.4.6	Determine the Caprolactam peak of the scan using the appropriate GC Reference and compare the results of the scan to the known
value of the standard.

 

		6.4.7	Follow the standard department procedure for the method calibration of the gas chromatograph, as stated in QADP-0008. If the
first injection

    	 

    	

    

Confidential Treatment Requested by AdvanSix
Inc.

 

falls
outside of ± 1% of
the known value of the internal standard, two successive injections of the standard must be obtained which agree within ±
1% of the known values(s) of the internal standard before the method is considered to be calibrated. The QA check sample result
must be within ±
2% of the expected prepared concentration value.

 

		6.5	Sample Analysis

 

		6.5.1	Following the manufacturer’s instructions, configure the CLASS-VP Data collection system to report the sample results
by Internal Standard calibration using the method program defined for this analysis. Refer to the current method settings in the
GC Reference. Enter the sample information and preparation weights into the sequence table.

 

		6.5.2	Using an ALS, equipped with a 10 mL
syringe, inject 1 mL of
each sample into the gas chromatograph operating as described in Step 6.4.3 and allow the Data collection software operate until
the completion of the scan.

 

		6.5.3	After injecting the sample, clean the syringe according to the steps described in 6.4.5.

 

		6.5.4	Using the CLASS-VP Software (as described in Step 6.4.2) determine the Caprolactam concentration in units of percent.

 

		6.6	Calculations

 

		6.6.1	Report the Caprolactam concentration to the nearest 0.1%. Results are to be reported to the nearest 0.1% with values of less
than 0.1% reported as <0.1%.

 

		6.6.1.1	Report results directly from the data report from the Class-VP software.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}]]